Chirikov V - Search Results

1

Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective study.

Bröckelmann PJ, Zagadailov EA, Corman SL, Chirikov V, Johnson C, Macahilig C, Seal B, Dalal MR, Illidge T. Bröckelmann PJ, et al. Among authors: chirikov v. Eur J Haematol. 2017 Dec;99(6):553-558. doi: 10.1111/ejh.12973. Epub 2017 Oct 16. Eur J Haematol. 2017. PMID: 28949403

2

Real-world effectiveness of brentuximab vedotin versus physicians' choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and Germany.

Zagadailov EA, Corman S, Chirikov V, Johnson C, Macahilig C, Seal B, Dalal MR, Bröckelmann PJ, Illidge T. Zagadailov EA, et al. Among authors: chirikov v. Leuk Lymphoma. 2018 Jun;59(6):1413-1419. doi: 10.1080/10428194.2017.1382698. Epub 2017 Oct 18. Leuk Lymphoma. 2018. PMID: 29045163

3

Multispecialist Care and Mortality in Hepatocellular Carcinoma.

Chirikov VV, Mullins CD, Hanna N, Breunig IM, Seal B, Shaya FT. Chirikov VV, et al. Am J Clin Oncol. 2015 Dec;38(6):557-63. doi: 10.1097/COC.0000000000000000. Am J Clin Oncol. 2015. PMID: 24064759

4

Clinical and Economic Burden of Out-of-Hospital Cardiac Arrest in US Commercial Insurance Population (2014 to 2019).

Chirikov VV, Corman S, Qiao Y, Huang X. Chirikov VV, et al. Am J Cardiol. 2022 Apr 15;169:42-50. doi: 10.1016/j.amjcard.2021.12.038. Epub 2022 Jan 19. Am J Cardiol. 2022. PMID: 35063266

5

Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare.

Shaya FT, Breunig IM, Seal B, Mullins CD, Chirikov VV, Hanna N. Shaya FT, et al. Among authors: chirikov vv. Pharmacoeconomics. 2014 Jan;32(1):63-74. doi: 10.1007/s40273-013-0109-7. Pharmacoeconomics. 2014. PMID: 24293197

6

The Real-World Lifetime Economic Burden of Urothelial Carcinoma by Stage at Diagnosis.

Aly A, Johnson C, Doleh Y, Chirikov V, Botteman M, Shenolikar R, Hussain A. Aly A, et al. Among authors: chirikov v. J Clin Pathw. 2020 May;6(4):51-60. J Clin Pathw. 2020. PMID: 32832698 Free PMC article.

7

Transarterial chemoembolization treatment: association between multiple treatments, cumulative expenditures, and survival.

Breunig IM, Shaya FT, Hanna N, Seal B, Chirikov VV, Daniel Mullins C. Breunig IM, et al. Among authors: chirikov vv. Value Health. 2013 Jul-Aug;16(5):760-8. doi: 10.1016/j.jval.2013.03.1630. Epub 2013 May 28. Value Health. 2013. PMID: 23947969 Free article.

8

Oral corticosteroid exposure and increased risk of related complications in patients with noninfectious intermediate, posterior, or panuveitis: Real-world data analysis.

Chirikov VV, Shah R, Kwon Y, Patel D. Chirikov VV, et al. Ophthalmic Epidemiol. 2019 Feb;26(1):27-46. doi: 10.1080/09286586.2018.1513042. Epub 2018 Sep 10. Ophthalmic Epidemiol. 2019. PMID: 30199301

9

Long-term Assessment of Healthcare Utilization 5 Years After Respiratory Syncytial Virus Infection in US Infants.

Simões EAF, Chirikov V, Botteman M, Kwon Y, Kuznik A. Simões EAF, et al. Among authors: chirikov v. J Infect Dis. 2020 Mar 28;221(8):1256-1270. doi: 10.1093/infdis/jiz278. J Infect Dis. 2020. PMID: 31165865

10

Decision support tools to optimize economic outcomes for type 2 diabetes.

Shaya FT, Chirikov VV. Shaya FT, et al. Among authors: chirikov vv. Am J Manag Care. 2011 Nov;17 Suppl 14:S377-83. Am J Manag Care. 2011. PMID: 22214425 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters